Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1030250284) titled 'Feasibility study of re-irradiation planning in definitive radiotherapy using the simultaneous integrated boost (SIB) technique for prostate cancer with pelvic lymph node metastases' on Aug. 6.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
Primary Sponsor: Murofushi Keiko
Condition:
Prostate Cancer
Intervention:
definitive radiation therapy using simultaneous integrated boost
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 06/08/2025
Target Sample Size: 20
To know more, visit http...